Nelson Blake Acquires 900 Shares of NXG NextGen Fund
CFO Nelson Blake of NXG NextGen Infrastructure Income Fund purchases 900 shares, signaling confidence in the company's future.
Brenner Melissa Anne Reports Dividend Equivalent Transaction
Brenner Melissa Anne has reported a transaction involving dividend equivalents for Match Group, indicating an increase in her ownership stake in the company.
Firy Inc. CFO Reports Stock Transactions in SEC Filing
Firy Inc.'s Chief Accounting Officer, Valli Todd, reports stock transactions in a recent SEC filing, indicating ongoing equity management.
Sherwin-Williams CFO Exercises Stock Options for 13,805 Shares
Benjamin E. Meisenzahl, CFO of Sherwin-Williams, exercised stock options for 13,805 shares, reflecting a commitment to executive compensation.
Maplebear CEO Chris Rogers Sells 24,060 Shares of Stock
Chris Rogers, CEO of Maplebear Inc., sold 24,060 shares of stock as part of a trading plan, reflecting ongoing management of his equity stake.
Moskowitz Raina reports dividend equivalents transaction
Moskowitz Raina discloses a transaction involving 29 dividend equivalents for Match Group, reflecting ongoing investment strategies in the tech sector.
Zeta Global's Ravella Satish Reports Stock Transactions
Ravella Satish, Chief Accounting Officer at Zeta Global, reports stock transactions including acquisitions and dispositions of shares.
Rapport Therapeutics director acquires 3,680 shares of stock
Rapport Therapeutics, Inc. director Paul M. Silva acquires 3,680 shares, signaling confidence in the company's growth and direction.
Rapport Therapeutics director acquires over 9,000 shares
John M. Maraganore, a director at Rapport Therapeutics, acquires over 9,000 shares, signaling confidence in the company’s future.
Campbell Kotzman Kelly Reports Dividend Equivalents Transaction
Campbell Kotzman Kelly has disclosed a transaction involving dividend equivalents, impacting their stake in Match Group, Inc.
Rapport Therapeutics director acquires 35,714 shares
Rapport Therapeutics, Inc. reports director Paul Steven M's acquisition of 35,714 shares, signaling confidence in the company's future.
Director Caulfield acquires 1,792 shares of Kontoor Brands
James T. Caulfield, director at Kontoor Brands, acquired 1,792 shares, showcasing confidence in the company's future in the men's furnishings market.
Lang James P. acquires shares via stock options at Sherwin-Williams
Lang James P. reports acquisition of 2,335 shares of Sherwin-Williams through stock options, reflecting the company's executive compensation strategy.
Jorgenrud Karl J Exercises Stock Options for Sherwin-Williams
Jorgenrud Karl J exercises stock options for 12,055 shares of Sherwin-Williams, reflecting confidence in the company's future.
Match Group's Philip Eigenmann Reports New Dividend Transactions
Philip Eigenmann, Chief Accounting Officer at Match Group, files new dividend equivalent transactions, highlighting ongoing equity management strategies.
Surrozen director Tim Kutzkey acquires over 1.5 million shares
Tim Kutzkey of Surrozen, Inc. acquired over 1.5 million shares, signaling strong investment interest in the biological products sector.
Guardant Health Director Acquires Additional Shares
Roberto Mignone, a director at Guardant Health, acquires more shares, signaling confidence in the company's future in the medical laboratory services sector.
Column Group Opportunity III GP, LP Reports Stock Transactions
Column Group Opportunity III GP, LP details significant stock transactions in Surrozen, Inc., reflecting ongoing investment in the biotech sector.
Binns Justin T acquires 12,055 shares in Sherwin Williams
Binns Justin T reports acquisition of 12,055 shares of Sherwin Williams Co, reflecting commitment to company growth and industry trends.
Match Group's Edgett Reports New Dividend Equivalent Transactions
Sean Edgett of Match Group disclosed new transactions involving dividend equivalents, reflecting ongoing compensation strategies in the tech industry.